Cidara

Cidara Therapeutics

This biotechnology company develops immunotherapies and long-acting antivirals for patients suffering from serious infectious diseases and solid tumours.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

ReViral

This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.

Invivyd

Invivyd develops monoclonal antibody therapies to protect immunocompromised patients from serious viral infectious diseases, including COVID-19 and measles.

RQ Bio

RQ Bio develops long-acting monoclonal antibodies to provide seasonal influenza protection for vulnerable and immunocompromised patients who cannot rely on vaccination alone.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Sidewinder Therapeutics

The biopharmaceutical company develops bispecific antibody-drug conjugates to provide precision medicines for patients with difficult-to-treat cancer and rare diseases.